Thiogenesis Therapeutics Corp (TTI.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,502 | 1,843 | 3,014 | 3,848 | 4,147 |
| Receivables | 68 | 49 | 57 | 88 | 74 |
| TOTAL | $3,625 | $1,940 | $3,133 | $3,983 | $4,254 |
| Non-Current Assets | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $3,625 | $1,940 | $3,133 | $3,983 | $4,254 |
| Liabilities | |||||
| Current Liabilities | |||||
| TOTAL | $1,472 | $1,484 | $994 | $558 | $106 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $1,472 | $1,484 | $994 | $558 | $106 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 51,836 | N/A | N/A | N/A | N/A |
| Common Shares | 19,912 | 16,214 | 16,214 | 16,137 | 15,670 |
| Retained earnings | -19,978 | -17,594 | -15,695 | -14,284 | -13,157 |
| Other shareholders' equity | 2,219 | 1,837 | 1,620 | 1,573 | 1,635 |
| TOTAL | $2,153 | $457 | $2,140 | $3,426 | $4,148 |
| Total Liabilities And Equity | $3,625 | $1,940 | $3,133 | $3,983 | $4,254 |